ResMed, Inc. (RMD)

230.87 -0.49 (-0.21%) USD  |  NYSE  |  Sep 02, 16:00
230.80 -0.07 (-0.03%) Pre-Market: 06:49
More

ResMed Cash and Short Term Investments (Quarterly) : 1.473B for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for RMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 1.473B
March 31, 2026 1.666B
December 31, 2025 1.426B
September 30, 2025 1.392B
June 30, 2025 1.223B
March 31, 2025 932.71M
December 31, 2024 521.94M
September 30, 2024 426.36M
June 30, 2024 238.36M
March 31, 2024 237.91M
December 31, 2023 210.25M
September 30, 2023 209.10M
June 30, 2023 227.89M
March 31, 2023 227.89M
December 31, 2022 253.20M
September 30, 2022 207.16M
June 30, 2022 273.71M
March 31, 2022 201.77M
December 31, 2021 194.48M
September 30, 2021 276.15M
June 30, 2021 295.28M
March 31, 2021 230.64M
December 31, 2020 255.86M
September 30, 2020 421.41M
June 30, 2020 463.16M
Date Value
March 31, 2020 352.86M
December 31, 2019 204.10M
September 30, 2019 172.15M
June 30, 2019 147.13M
March 31, 2019 146.51M
December 31, 2018 149.47M
September 30, 2018 230.19M
June 30, 2018 188.70M
March 31, 2018 704.28M
December 31, 2017 858.90M
September 30, 2017 811.10M
June 30, 2017 821.94M
March 31, 2017 827.31M
December 31, 2016 788.15M
September 30, 2016 781.66M
June 30, 2016 731.43M
March 31, 2016 718.50M
December 31, 2015 658.80M
September 30, 2015 822.05M
June 30, 2015 717.25M
March 31, 2015 866.32M
December 31, 2014 880.70M
September 30, 2014 881.69M
June 30, 2014 905.73M
March 31, 2014 938.56M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Koninklijke Philips NV 2.045B
Accuray, Inc. 41.23M
Micron Solutions, Inc. --
Medtronic Plc --
Orthofix Medical, Inc. 104.40M